Regenerative MedicineTutorialAdvanced
p16/p21-SASP Pathways: Molecular Targets for Senolytic Drug Development
Why one senolytic works in one tissue and fails in another, how the SASP changes over time, and how newer strategies try to engineer around platelet toxicity. Then a critical read of what the human trials can support.
Tuesday, April 14, 2026 11 views
About This Tutorial
Why one senolytic works in one tissue and fails in another, how the SASP changes over time, and how newer strategies try to engineer around platelet toxicity. Then a critical read of what the human trials can support.
Tutorials Are a Paid Feature
Interactive tutorials with quizzes and score tracking are available to Practitioner members and above. Sign in to try one tutorial for free!
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: